The FDA have now approved a version of Medtroinic's Simplera Sync sensor that now pairs with the MiniMed™ 780G insulin pump, marking a major step forward for users of automated insulin delivery systems.
What’s new?
The Simplera Sync isn’t a well-known brand-new name in the CGM space—last summer, Medtronic got FDA approval for the sensor, which was a big leap forward thanks to its slimmer design, and as other CGMs requires no fingerpricks. But what makes this latest approval stand out is its integration, communicating directly with the MiniMed 780G system - Medtronic’s most advanced insulin pump with automated insulin delivery.
For those already familiar with the 780G, you know it includes Meal Detection Technology—a smart algorithm that detects glucose spikes and adjusts insulin delivery, even when you miss a bolus or miscalculate carbs. This new integration with a smaller, more user-friendly CGM sensor is likely to improve both convenience and glucose control.
A Closer Look at the 780G system
The MiniMed 780G has been a focal point of Medtronic’s efforts to revitalise its diabetes business after facing some regulatory hurdles. With glucose targets that can go as low as 100 mg/dL and smart correction boluses, it’s designed to reduce time spent in hyperglycemia and simplify life for users who are balancing the constant demands of T1D—or potentially even T2D in the near future.
Medtronic is planning a limited release of the Simplera Sync for pump use starting this autumn. In the meantime, they’re also working with Abbott to develop a custom CGM designed exclusively for Medtronic devices. It’s a bold move aimed at strengthening their place in a competitive US market.
***
If you're not currently a member of our community please join us by subscribing here. We look forward to welcoming you!
***
Disclaimer
Blogs and publications on this website are independent of any involvement by medtech companies or diabetes related charities. To ensure there is no bias, we do not accept any products, freebies or other material from any medtech provider. Except where credited otherwise, all materials are copyright ©️Love My Libre Ltd.Love My Libre is not associated or affiliated with Abbott or FreeStyle Libre.
Content here and on our website www.lovemylibre.com does not constitute medical advice or replace the relationship between you and healthcare professionals nor the advice you receive from them.The author of this blog has type 1 diabetes and uses the FreeStyle Libre 2 Plus which is provided on NHS prescription.
Leave a comment (all fields required). Please note, we are unable to respond to individual comments posted here.